Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Current Leases: 2023-2024

Historic Current Leases for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $1.6 million.

  • Inhibrx Biosciences' Current Leases rose 22.45% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 22.45%. This contributed to the annual value of $1.6 million for FY2024, which is 22.69% down from last year.
  • Inhibrx Biosciences' Current Leases amounted to $1.6 million in FY2024, which was down 22.69% from $2.1 million recorded in FY2023.
  • Inhibrx Biosciences' Current Leases' 5-year high stood at $2.1 million during FY2023, with a 5-year trough of $1.6 million in FY2024.
  • In the last 2 years, Inhibrx Biosciences' Current Leases had a median value of $1.8 million in 2023 and averaged $1.8 million.
  • Data for Inhibrx Biosciences' Current Leases shows a maximum YoY dropped of 22.69% (in 2024) over the last 5 years.
  • Over the past 2 years, Inhibrx Biosciences' Current Leases (Yearly) stood at $2.1 million in 2023, then decreased by 22.69% to $1.6 million in 2024.